Cytokinetics Inc Tangible Net Worth Ratio
Cytokinetics Inc tangible net worth ratio. Cytokinetics Inc (CYTK) has a Tangible Net Worth Ratio of 100.0% as of June 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($108.55 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Cytokinetics Inc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Cytokinetics Inc (2004–2021)
Tangible net worth ratio of Cytokinetics Inc from 2004 to 2021. This chart shows how Cytokinetics Inc's Tangible Net Worth Ratio has changed across 17 annual periods from 2004 to 2021. As of June 2024, the ratio stands at 100.0%, reflecting net assets of $108.55 Million with intangible assets of $0.00 USD. Check Cytokinetics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Cytokinetics Inc Tangible Net Worth Ratio by Year (2004–2021)
Cytokinetics Inc tangible net worth ratio by year from 2004 to 2021. The table below presents the year-by-year Tangible Net Worth Ratio for Cytokinetics Inc from 2004 to 2021, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see CYTK stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | $243.86 Million | $0.00 | $841.32 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $113.38 Million | $0.00 | $533.80 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $25.93 Million | $0.00 | $211.18 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $109.84 Million | $0.00 | $294.81 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $94.36 Million | $0.00 | $170.14 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $68.59 Million | $0.00 | $115.24 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $92.06 Million | $0.00 | $132.97 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $54.44 Million | $0.00 | $83.19 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $71.44 Million | $0.00 | $77.55 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $48.18 Million | $0.00 | $52.77 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $70.52 Million | $0.00 | $77.99 Million | ▲ +0.0 pp |
| 2009 | 100.0% | $101.43 Million | $0.00 | $122.60 Million | ▲ +0.0 pp |
| 2008 | 100.0% | $49.77 Million | $0.00 | $87.45 Million | ▲ +0.0 pp |
| 2007 | 100.0% | $99.92 Million | $0.00 | $155.37 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $106.31 Million | $0.00 | $169.52 Million | ▲ +0.0 pp |
| 2005 | 100.0% | $73.56 Million | $0.00 | $91.46 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $107.56 Million | $0.00 | $128.10 Million | — |